Since Martin Shkreli announced that he would lower the price of Daraprim by an unnamed amount at some point in the future; as of this writing, he has not done so.1 Critics of Shkreli claim that the announcement to lower the price was merely a tactic to placate critics.2 Shkreli has responded by stating that such…
Author: Avni J. Patel
Pharmaceutical Pricing: The Intersection of Big Business and Healthcare
Until recently, Daraprim was a little known name.1 That is, until Turing Pharmaceuticals acquired the drug in August and increased the price of the drug from $13.50 to $750 per pill.2 Daraprim, known generically as pyrimethamine, is used mainly to “treat toxoplasmosis, a parasite infection that can cause serious or even life-threatening problems for babies…